Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Anticancer Research|August 30, 2008
PET-CT in recurrent ovarian cancer: impact on treatment planningMiriam S Lenhard, Alexander Burges, Thorsten R C Johnson, et al.
Clinical Chemistry and Laboratory Medicine|July 5, 2008
Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access OV Monitor assay on the UniCel Dxl 800 Immunoassay SystemStefan Holdenrieder, Rafael Molina, Massimo Gion, et al.
Clinical Chemistry and Laboratory Medicine|March 26, 2009
Predictive value of CA 125 and CA 72-4 in ovarian borderline tumorsMiriam S Lenhard, Stefanie Nehring, Dorothea Nagel, et al.
Clinical Chemistry and Laboratory Medicine|July 5, 2008
Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access BR Monitor assay on the UniCel Dxl 800 Immunoassay SystemRafael Molina, Massimo Gion, Axel Gressner, et al.
Anticancer Research|July 26, 2007
Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolismStefan Holdenrieder, Peter Eichhorn, Ulrich Beuers, et al.
Onkologie|August 8, 2012
Anthracycline-induced cardiotoxicity: cardiac monitoring by continuous wave-Doppler ultrasound cardiac output monitoring and correlation to echocardiographySandra Geiger, Hans Joachim Stemmler, Patricia Suhl, et al.
Clinical Chemistry and Laboratory Medicine|September 20, 2011
The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian massesMiriam Lenhard, Petra Stieber, Linda Hertlein, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 19, 2010
Prognostic relevance of CA 19-9, CEA, CRP, and LDH kinetics in patients treated with palliative second-line therapy for advanced pancreatic cancerMichael Haas, Rüdiger P Laubender, Petra Stieber, et al.
International Journal of Cancer|February 25, 2012
Prognostic role of methylated free circulating DNA in colorectal cancerAlexander B Philipp, Petra Stieber, Dorothea Nagel, et al.
Clinical Chemistry and Laboratory Medicine|July 5, 2008
Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access GI Monitor assay on the UniCel Dxl 800 Immunoassay SystemPetra Stieber, Rafael Molina, Massimo Gion, et al.
Pageof 9